These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34936650)

  • 41. Comparison of health-oriented cross-regional allocation strategies for the COVID-19 vaccine: a mathematical modelling study.
    Yang T; Deng W; Liu Y; Deng J
    Ann Med; 2022 Dec; 54(1):941-952. PubMed ID: 35393922
    [TBL] [Abstract][Full Text] [Related]  

  • 42. BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers.
    Lustig Y; Sapir E; Regev-Yochay G; Cohen C; Fluss R; Olmer L; Indenbaum V; Mandelboim M; Doolman R; Amit S; Mendelson E; Ziv A; Huppert A; Rubin C; Freedman L; Kreiss Y
    Lancet Respir Med; 2021 Sep; 9(9):999-1009. PubMed ID: 34224675
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Why Oxford's positive COVID vaccine results are puzzling scientists.
    Callaway E
    Nature; 2020 Dec; 588(7836):16-18. PubMed ID: 33230278
    [No Abstract]   [Full Text] [Related]  

  • 44. Using syndromic measures of mortality to capture the dynamics of COVID-19 in Java, Indonesia, in the context of vaccination rollout.
    Djaafara BA; Whittaker C; Watson OJ; Verity R; Brazeau NF; Widyastuti ; Oktavia D; Adrian V; Salama N; Bhatia S; Nouvellet P; Sherrard-Smith E; Churcher TS; Surendra H; Lina RN; Ekawati LL; Lestari KD; Andrianto A; Thwaites G; Baird JK; Ghani AC; Elyazar IRF; Walker PGT
    BMC Med; 2021 Jun; 19(1):146. PubMed ID: 34144715
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dynamics of the COVID-19 epidemic in the post-vaccination period in Korea: a rapid assessment.
    Min KD; Tak S
    Epidemiol Health; 2021; 43():e2021040. PubMed ID: 34082498
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mathematical modelling of the 100-day target for vaccine availability after the detection of a novel pathogen: A case study in Indonesia.
    Bilgin GM; Munira SL; Lokuge K; Glass K
    Vaccine; 2024 Aug; 42(21):126163. PubMed ID: 39060201
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Modeling outbreaks of COVID-19 in China: The impact of vaccination and other control measures on curbing the epidemic.
    Zha W; Ni H; He Y; Kuang W; Zhao J; Fu L; Dai H; Lv Y; Zhou N; Yang X
    Hum Vaccin Immunother; 2024 Dec; 20(1):2338953. PubMed ID: 38658178
    [TBL] [Abstract][Full Text] [Related]  

  • 48. COVID-19 vaccination and treatment in vulnerable populations.
    Delgoffe GM
    Immunology; 2022 Feb; 165(2):141-142. PubMed ID: 35018636
    [No Abstract]   [Full Text] [Related]  

  • 49. Who should be vaccinated first? Comparing vaccine prioritization strategies in Israel and European countries using the Covid-19 Health System Response Monitor.
    Cylus J; Panteli D; van Ginneken E
    Isr J Health Policy Res; 2021 Feb; 10(1):16. PubMed ID: 33608023
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hashtag as a new weapon to resist the COVID-19 vaccination policy: a qualitative study of the anti-vaccine movement in Brazil, USA, and Indonesia.
    Khadafi R; Nurmandi A; Qodir Z; Misran
    Hum Vaccin Immunother; 2022 Dec; 18(1):2042135. PubMed ID: 35240923
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Modelling the impact of delaying vaccination against SARS-CoV-2 assuming unlimited vaccine supply.
    Amaku M; Covas DT; Coutinho FAB; Azevedo RS; Massad E
    Theor Biol Med Model; 2021 Jul; 18(1):14. PubMed ID: 34325717
    [TBL] [Abstract][Full Text] [Related]  

  • 52. How COVID vaccines shaped 2021 in eight powerful charts.
    Mallapaty S; Callaway E; Kozlov M; Ledford H; Pickrell J; Van Noorden R
    Nature; 2021 Dec; 600(7890):580-583. PubMed ID: 34916666
    [No Abstract]   [Full Text] [Related]  

  • 53. Predictive analysis of COVID-19 eradication with vaccination in India, Brazil, and U.S.A.
    Chaturvedi D; Chakravarty U
    Infect Genet Evol; 2021 Aug; 92():104834. PubMed ID: 33798755
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of vaccine prioritization strategies on mitigating COVID-19: an agent-based simulation study using an urban region in the United States.
    Tatapudi H; Das R; Das TK
    BMC Med Res Methodol; 2021 Dec; 21(1):272. PubMed ID: 34865617
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A Recursive Model of the Spread of COVID-19: Modelling Study.
    Ilyin SO
    JMIR Public Health Surveill; 2021 Apr; 7(4):e21468. PubMed ID: 33871381
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Assessing the knowledge and skill of vaccination staff at Adult Vaccination Counters for COVID-19 vaccines: Simulated client method.
    Qamar W; Qayum M; Sadiq N
    PLoS One; 2021; 16(12):e0261286. PubMed ID: 34941905
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Public health impact of delaying second dose of BNT162b2 or mRNA-1273 covid-19 vaccine: simulation agent based modeling study.
    Romero-Brufau S; Chopra A; Ryu AJ; Gel E; Raskar R; Kremers W; Anderson KS; Subramanian J; Krishnamurthy B; Singh A; Pasupathy K; Dong Y; O'Horo JC; Wilson WR; Mitchell O; Kingsley TC
    BMJ; 2021 May; 373():n1087. PubMed ID: 33980718
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The first report on coronavirus disease 2019 (COVID-19) vaccine refusal by patients with solid cancer in Italy: Early data from a single-institute survey.
    Di Noia V; Renna D; Barberi V; Di Civita M; Riva F; Costantini G; Aquila ED; Russillo M; Bracco D; La Malfa AM; Giannarelli D; Cognetti F
    Eur J Cancer; 2021 Aug; 153():260-264. PubMed ID: 34183225
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of immunity loss on the optimal vaccination strategy for an age-structured epidemiological model.
    Bouhali A; Aribi WB; Miled SB; Kebir A
    Math Biosci Eng; 2024 Jun; 21(6):6372-6392. PubMed ID: 39176430
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Optimal vaccine allocation strategy: Theory and application to the early stage of COVID-19 in Japan.
    Kuniya T; Nakata T; Fujii D
    Math Biosci Eng; 2024 Jun; 21(6):6359-6371. PubMed ID: 39176429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.